Fusion event
HBV-chr5 integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CCGTCTGTGCCTTCTCATCTGCCGGACCGTGTGCACTTCGCTTCACCTCTGCACGTCGCATGGAGACCACCGTGAACGCCCACCAAATATTGCCCAAGGT| |CTTACATAAGAGGACTCTTGGACTCTCAGCAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAG
End
52980534/53684704 (Hg38)
Nearest miRNA
hsa-mir-10397/Upstream/15127143; hsa-mir-103a-1/Downstream/266800;
Upstream sequence
AACTTTTCATAGGCAGATACCGTAACTCAAAATGTTTTTTTAATCTGGTTGGTAATGTCCTCTGGGCTTTAGAGTATCTATTTTCCCTTAATCATTTCAG
Downstream sequence
TTCCATTTAATTTGAAAAATGCACTTACAGGCAAATAGCCTGTAGATATACAGAGGTAAatgtccaaagatgtttattgtaaagttgttgctagtagcta
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.